InterCure Ltd. (TLV:INCR)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
527.30
-14.00 (-2.59%)
Jun 5, 2025, 5:24 PM IDT
-49.54%
Market Cap 250.58M
Revenue (ttm) 238.85M
Net Income (ttm) -67.80M
Shares Out 47.16M
EPS (ttm) -1.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 63,620
Average Volume 40,128
Open 530.00
Previous Close 541.30
Day's Range 527.30 - 557.70
52-Week Range 454.10 - 1,035.00
Beta 0.58
RSI 41.39
Earnings Date May 29, 2025

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. [Read more]

Sector Healthcare
Founded 1994
Employees 320
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol INCR
Full Company Profile

Financial Performance

In 2024, InterCure's revenue was 238.85 million, a decrease of -32.82% compared to the previous year's 355.55 million. Losses were -67.80 million, 9.42% more than in 2023.

Financial Statements

News

There is no news available yet.